Psychopharmacology in supportive care of cancer: a review for the clinician. IV. Other psychotropic agents.
Besides benzodiazepine, antidepressant and neuroleptic agents, all of which have established roles in supportive care, other psychotropic drugs deserve consideration in selected conditions affecting patients with advanced cancer. This article briefly reviews relevant aspects of miscellaneous psychotropics available for secondline treatment, including nonbenzodiazepine sedative, hypnotic and anxiolytic drugs, anaesthetic agents, stimulants, and analgesic adjuvants acting on the central nervous system. The proper use of such subsidiary psychotropic agents requires that both their specificities and the particular characteristics of palliative care patients are taken into account.
Buclin
T
T
Division de Pharmacologie Clinique, Centre Hospitalier Universitaire, Vaudois, Lausanne, Switzerland.
Mazzocato
C
C
Berney
A
A
Stiefel
F
F
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D002492:Central Nervous System Depressants / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000523:psychology; D010146:Pain / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D002492:Central Nervous System Depressants; D000697:Central Nervous System Stimulants; D011619:Psychotropic Drugs